Cargando…
Response to The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361545/ https://www.ncbi.nlm.nih.gov/pubmed/32838110 http://dx.doi.org/10.1002/rth2.12417 |
_version_ | 1783559380996718592 |
---|---|
author | Riker, Richard R. May, Teresa L. Fraser, Gilles L. Gagnon, David J. Bandara, Mahesh Zemrak, Wes Seder, David B. |
author_facet | Riker, Richard R. May, Teresa L. Fraser, Gilles L. Gagnon, David J. Bandara, Mahesh Zemrak, Wes Seder, David B. |
author_sort | Riker, Richard R. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7361545 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73615452020-07-15 Response to The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19 Riker, Richard R. May, Teresa L. Fraser, Gilles L. Gagnon, David J. Bandara, Mahesh Zemrak, Wes Seder, David B. Res Pract Thromb Haemost Letters to the Editor John Wiley and Sons Inc. 2020-08-04 /pmc/articles/PMC7361545/ /pubmed/32838110 http://dx.doi.org/10.1002/rth2.12417 Text en © 2020 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Letters to the Editor Riker, Richard R. May, Teresa L. Fraser, Gilles L. Gagnon, David J. Bandara, Mahesh Zemrak, Wes Seder, David B. Response to The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19 |
title | Response to The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19 |
title_full | Response to The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19 |
title_fullStr | Response to The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19 |
title_full_unstemmed | Response to The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19 |
title_short | Response to The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19 |
title_sort | response to the challenges of diagnosing heparin‐induced thrombocytopenia in patients with covid‐19 |
topic | Letters to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361545/ https://www.ncbi.nlm.nih.gov/pubmed/32838110 http://dx.doi.org/10.1002/rth2.12417 |
work_keys_str_mv | AT rikerrichardr responsetothechallengesofdiagnosingheparininducedthrombocytopeniainpatientswithcovid19 AT mayteresal responsetothechallengesofdiagnosingheparininducedthrombocytopeniainpatientswithcovid19 AT frasergillesl responsetothechallengesofdiagnosingheparininducedthrombocytopeniainpatientswithcovid19 AT gagnondavidj responsetothechallengesofdiagnosingheparininducedthrombocytopeniainpatientswithcovid19 AT bandaramahesh responsetothechallengesofdiagnosingheparininducedthrombocytopeniainpatientswithcovid19 AT zemrakwes responsetothechallengesofdiagnosingheparininducedthrombocytopeniainpatientswithcovid19 AT sederdavidb responsetothechallengesofdiagnosingheparininducedthrombocytopeniainpatientswithcovid19 |